|
DCAF6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.986000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.244400E-01 |
| Normal-vs-Stage2 |
4.053200E-01 |
| Normal-vs-Stage3 |
2.391600E-01 |
| Normal-vs-Stage4 |
8.898200E-01 |
| Stage1-vs-Stage2 |
3.991600E-01 |
| Stage1-vs-Stage3 |
1.397580E-01 |
| Stage1-vs-Stage4 |
7.579800E-01 |
| Stage2-vs-Stage3 |
1.153580E-01 |
| Stage2-vs-Stage4 |
3.963600E-01 |
| Stage3-vs-Stage4 |
3.858800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.418600E-01 |
| Normal-vs-AfricanAmerican |
1.497540E-02 |
| Normal-vs-Asian |
1.601820E-01 |
| Caucasian-vs-AfricanAmerican |
3.322400E-02 |
| Caucasian-vs-Asian |
1.085640E-01 |
| AfricanAmerican-vs-Asian |
4.009000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.128000E-01 |
| Normal-vs-Female |
7.871800E-01 |
| Male-vs-Female |
5.953200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.028400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.305600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.211800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.974600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.883400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.107000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.659200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.922200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.113600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.212200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.157800E-01 |
| Classical-VS-Follicular |
1.56340000001531E-06 |
| Classical-VS-Other |
3.397400E-01 |
| Classical-VS-Normal |
1.292370E-01 |
| Tall-VS-Follicular |
2.598000E-03 |
| Tall-VS-Other |
3.299800E-01 |
| Tall-VS-Normal |
3.648000E-01 |
| Follicular-VS-Other |
5.667200E-01 |
| Follicular-VS-Normal |
5.644300E-03 |
| Other-VS-Normal |
6.476400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.073600E-01 |
| Normal-vs-N1 |
4.540200E-01 |
| N0-vs-N1 |
9.901800E-01 |
|
|
